Soria, J.C., Tan, D.S.W., Chiari, R., Wu, Y.L., Paz-Ares, L. et al. (2017) First-Line Ceritinib versus Platinum-Based Chemotherapy in Advanced ALK-Rearranged Non- Small-Cell Lung Cancer (ASCEND-4): A Randomized, Open-Label, Phase 3 Study. The Lancet, 389, 917-929.
https://doi.org/10.1016/S0140-6736(17)30123-X
https://www.sciencedirect.com/science/article/pii/S014067361730123X

has been cited by the following article:

• TITLE: Considerations and Experience in the Treatment of Lung Cancer with VMAT SBRT + DIBH in Arms-Down Position

  AUTHORS: Yulin Song, Boris Mueller, Kenneth Dow, Ziad Saleh, Xiaoli Tang, Melissa Zinovoy, Daphna Gelblum, Borys Mychalczak

  KEYWORDS: Lung Cancer, VMAT, SBRT, DIBH, Arms-Down Position

  JOURNAL NAME: International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, Vol.10 No.2, May 24, 2021

  ABSTRACT: The arms-up position is the most common treatment position adopted for lung cancer patients treated with radiation therapy. However, many elderly or frail patients have shoulder problems and cannot tolerate such an overstretched position for an extended period. Therefore, the arms-down position becomes the only alternative for this group of patients during radiation therapy. Even though the arms-down position is not ideal, it does provide a stable and comfortable patient immobilization position for radiation treatments that require a longer delivery time, such as stereotactic body radiation therapy (SBRT). In this study, we designed a protocol to treat lung cancer patients with VMAT stereotactic body radiation therapy (VMAT SBRT) and deep inspiration breath-hold (DIBH) in the arms-down position. Our initial clinical experience with this protocol indicates that it is reliable for patient immobilization and accurate in delivered dosimetry.